Label: Information for the User
Rosuvastatina Viatris 20 mg Film-Coated Tablets
Read this label carefully before you start taking this medicine, because it contains important information for you.
6. Contents of the pack and additional information
Rosuvastatina Viatriscontains the active ingredient rosuvastatina, which belongs to a group of medications called statins.
You have been prescribedthis medicationbecause:
You have been told to take a statin because changes made to your diet and increased physical exercise have not been enough to correct your cholesterol levels. You must maintain a diet that helps to lower cholesterol and continue exercising while on treatment with rosuvastatina.
Or
A heart attack, stroke, and other health problems may be caused by a disease called atherosclerosis. Atherosclerosis is caused by the formation of fatty deposits in your arteries.
Why it is important to continue taking Rosuvastatina Viatris:
Do not take Rosuvastatina Viatris
If you find yourself in any of the above situations (or are unsure), please consult your doctor.
Additionally, do not take rosuvastatina 40mg (the highest dose):
If you find yourself in any of the above situations (or are unsure), please consult your doctor.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Rosuvastatina Viatris:
If you find yourself in any of the above situations (or are unsure):
Do not take Rosuvastatina Viatris 40 mg (the highest dose) and consult your doctor or pharmacist before starting to take any dose of Rosuvastatina Viatris.
During treatment
Inform your doctor or pharmacist immediately if you have unexplained or repeated muscle pain or cramps, especially if you have general discomfort or fever. Consult your doctor or pharmacist if you have persistent muscle weakness. You may need additional tests and medications to diagnose and treat it.
Inform your doctor or pharmacist if you develop persistent cough, shortness of breath, or difficulty breathing. This medication may cause lung scarring and may need to be reviewed by your doctor.
Be especially careful with Rosuvastatina Viatris:
Severe skin reactions, including Stevens-Johnson syndrome and drug reaction with eosinophilia and systemic symptoms (DRESS), have been reported in association with Rosuvastatina Viatris treatment. Stop using Rosuvastatina Viatris and seek medical attention immediately if you notice any of the symptoms described in section 4.
In a small number of people, statins can affect the liver.This is identified by a simple test that looks for an increase in liver enzymes in the blood. For this reason, your doctor usually performs this blood test (liver function test) before and during treatment with Rosuvastatina Viatris.
While taking this medication, your doctor will closely monitor you if you have diabetes or are at risk of developing it. You are likely to be at risk of developing diabetes if you have high blood sugar and fat levels, are overweight, and have high blood pressure.
Children and adolescents
Older adults
OthermedicationsandRosuvastatina Viatris
The effects of these medications may be modified by rosuvastatina or may change the effect of rosuvastatina.
If you have totake acidfusidicoral to treata bacterial infectionyou will have tostop usingthis medication.Your doctorwill indicatewhen you canreinitiatethe treatment withrosuvastatina.The use ofrosuvastatinawith acidfusidic may producemuscle weakness, sensitivity or pain (rhabdomyolysis).For more information on rhabdomyolysis, see section 4.
Pregnancy and breastfeeding
Do not take rosuvastatina if you are pregnant or breastfeeding. If you become pregnant while taking rosuvastatina, stop taking it immediately and inform your doctor. Women should avoid becoming pregnant during treatment with rosuvastatina using an appropriate contraceptive method.
If you are pregnant or breastfeeding, think you may be pregnant, or intend to become pregnant, consult your doctor or pharmacist before taking this medication.
Driving and operating machinery
Most patients can drive vehicles and use machines during rosuvastatina treatment as it will not affect their ability. However, some people may feel dizzy during rosuvastatina treatment. If you feel dizzy, consult your doctor before attempting to drive or use machines.
Rosuvastatina Viatris contains lactose
This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
The complete list of components can be found insection 6 of this leaflet.
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Usual doses in adults
If you are taking Rosuvastatina Viatris for high cholesterol levels:
Starting dose
Your treatment with rosuvastatina should start with a dose of 5 mg or 10 mg, even if you have taken a higher dose of another statin previously. The choice of starting dose will depend on:
Check with your doctor or pharmacist which is the best starting dose of rosuvastatina for you.
Your doctor may decide to start treatment with the lower dose (5 mg) if:
Dose increase and maximum daily dose
Your doctor may decide to increase your dose. This is to ensure you are taking the right dose of rosuvastatina for you. If you started with a dose of 5 mg, your doctor may decide to double the dose to 10 mg, then to 20 mg, and later to 40 mg, if necessary. If you started with a dose of 10 mg, your doctor may decide to double the dose to 20 mg and then to 40 mg, if necessary. There will be a four-week interval between each dose adjustment.
The maximum daily dose of rosuvastatina is 40 mg. This dose is only for patients with high cholesterol levels and a high risk of having a heart attack or stroke, whose cholesterol levels do not decrease enough with 20 mg.
If you are taking rosuvastatina to reduce the risk of having a heart attack, a stroke, or related health problems:
The recommended dose is 20 mg per day. However, your doctor may decide to use a lower dose if you have any of the factors mentioned earlier.
Use in children and adolescents aged 6-17 years
The dose range in children and adolescents aged 6 to 17 years is 5 mg to 20 mg once a day. The usual recommended starting dose is 5 mg per day. Your doctor may increase your dose gradually to reach the dose of rosuvastatina that is right for treating your condition. The maximum recommended daily dose of rosuvastatina is 10 mg or 20 mg for children aged 6 to 17 years, depending on the underlying disease being treated. Take the dose indicated by your doctor once a day.Do notadminister 40 mg doses of rosuvastatina to children.
Swallowing the tablets
Swallow each tablet whole with water.
Take rosuvastatina once a day. You can take it at any time of the daywithorwithoutfood.
Try to take the tablets at the same time every day. This will help you remember to take them.
Regular cholesterol level checks
It is essential that you visit your doctor regularly for cholesterol checks, to ensure that your cholesterol levels have normalized and remain at appropriate levels.
Your doctor may decide to increase your dose to ensure you are taking the right dose of rosuvastatina for you.
If you take more Rosuvastatina Viatris than you should
Contact your doctor or nearest hospital for advice.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you enter a hospital or receive treatment for another condition, inform the healthcare staff that you are taking rosuvastatina.
If you forget to take Rosuvastatina Viatris
Do not worry, simply take the next scheduled dose at the scheduled time. Do not take a double dose to compensate for a missed dose.
If you interrupt treatment with Rosuvastatina Viatris
Consult your doctor if you want to stop treatment with rosuvastatina. Your cholesterol levels may increase again if you stop taking rosuvastatina.
Consult your doctor or pharmacist if you have any doubts about the use of this medication.
It is important that you know which side effects may occur.They are usually mild and disappear within a short period of time, however, some may be serious and require medical attention.
Stop taking rosuvastatin and seek medical attention immediately if you experience any of the following allergic or skin reactions:
Also, stop taking rosuvastatin and consult your doctor immediately if you experiencerepeated or unexplained muscle weakness that lasts longer than expected.Muscle symptoms are more common in children and adolescents than in adults. Like other statins, a very small number of people have experienced unpleasant muscle side effects, which, very rarely, have resulted in a potentially fatal muscle injury calledrabdomiolysis.
Also, you may observe the following side effects that could be signs of a serious problem. Seek medical help immediately if you observe any of the following symptoms::
Other possible side effects
Frequent (may affect1 in 10 people):
Rare (may affect1 in 100 people):
Very rare (may affect1 in 1,000 people):
Very rare (may affect1 in 10,000 people):
Frequency not known(cannot be estimated from available data):
Consult your doctor if you experience weakness in your arms or legs that worsens after periods of activity, double vision, eyelid drooping, difficulty swallowing, or difficulty breathing.
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Medications should not be disposed of through drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of RosuvastatinViatris
The active ingredient is rosuvastatin.
Each tablet contains 20 mg of rosuvastatin (as rosuvastatin calcium).
The other components are:
Core of the tablet:
Microcrystalline cellulose, lactose monohydrate, colloidal anhydrous silica, crospovidone, magnesium oxide, magnesium stearate, red iron oxide (E-172).
Coating:
Lactose monohydrate, hypromellose (E-464), titanium dioxide (E-171), triacetin, yellow iron oxide (E-172), red iron oxide (E-172), black iron oxide (E-172).
Appearance of the product and contents of the package
Film-coated, biconvex, round, pink tablets, marked with “M” on one face and “RS2” on the other.
Rosuvastatin Viatris is available in blister packs of 14, 15, 28, 30, 56, 60, 84, 90, and 98 tablets or in plastic bottles of 28, 30, 56, 60, 84, and 90 tablets.
The bottles have a screw-top cap containing a desiccant. Do not eat the desiccant.
Not all package sizes may be marketed.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder
Viatris Limited
Damastown Industrial Park
Mulhuddart, Dublin 15
Dublin
Ireland
Responsible manufacturer
McDermott Laboratories Ltd. T/A Gerard Laboratories,
35/36 Baldoyle Industrial Estate, Grange Road,
Dublin 13, Ireland
or
Generics (UK) Limited,
Station Close, Potters Bar,
EN6 1TL, United Kingdom
or
Mylan Hungary Ltd.
Mylan utca 1.
Komárom, 2900
Hungary
For more information about this medicine, please contact the local representative of the marketing authorization holder:
Viatris Pharmaceuticals, S.L.U.
C/ General Aranaz, 86
28027 - Madrid
Spain
This medicine is authorized in the EEA member states and in the United Kingdom (Northern Ireland) under the following names:
Belgium:Rosuvastatine Viatris 20 mg filmomhulde tabletten
Bulgaria:Rosuvastatin Viatris 20 mg
Cyprus:Rosuvastatin Mylan 20 mg Film-coated Tablets
Croatia:Rosacol 20 mg filmom obložene tablete
Denmark:Rosuvastatin Viatris 20 mg
Spain:Rosuvastatina Viatris 20 mg comprimidos recubiertos con película EFG
France:Rosuvastatine Viatris 20 mg comprimé pelliculé
Greece:Rosuvastatin / Mylan
Ireland:Rosuvastatin Viatris 20 mg film-coated tablet
Italy:Rosuvastatina Mylan
Luxembourg:Rosuvastatine Viatris 20 mg comprimés pelliculés
Netherlands:Rosuvastatine Mylan 20 mg filmomhulde tabletten
Portugal:Rosuvastatina Mylan
United Kingdom (Northern Ireland): Rosuvastatin 20 mg film-coated tablets
Czech Republic:Rosuvastatin Viatris
Sweden:Rosuvastatin Viatris 20 mg
Last review date of this leaflet:February 2025
For detailed information about this medicine, please visit the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)https://www.aemps.gob.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.